Jeffrey R. Marks
Jeffrey R. Marks
Verified email at mc.duke.edu
Title
Cited by
Cited by
Year
Comprehensive molecular portraits of human breast tumours
Cancer Genome Atlas Network
Nature 490 (7418), 61, 2012
62612012
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild, G Yao, JT Chang, Q Wang, A Potti, D Chasse, MB Joshi, ...
Nature 439 (7074), 353-357, 2006
20142006
Predicting the clinical status of human breast cancer by using gene expression profiles
M West, C Blanchette, H Dressman, E Huang, S Ishida, R Spang, H Zuzan, ...
Proceedings of the National Academy of Sciences 98 (20), 11462-11467, 2001
15532001
BRCA1 mutations in primary breast and ovarian carcinomas
PA Futreal, Q Liu, D Shattuck-Eidens, C Cochran, K Harshman, ...
Science 266 (5182), 120-122, 1994
15021994
Comprehensive molecular portraits of invasive lobular breast cancer
G Ciriello, ML Gatza, AH Beck, MD Wilkerson, SK Rhie, A Pastore, ...
Cell 163 (2), 506-519, 2015
8852015
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
CK Anders, DS Hsu, G Broadwater, CR Acharya, JA Foekens, Y Zhang, ...
Journal of clinical oncology 26 (20), 3324-3330, 2008
7612008
Genomic signatures to guide the use of chemotherapeutics
A Potti, HK Dressman, A Bild, RF Riedel, G Chan, R Sayer, J Cragun, ...
Nature medicine 12 (11), 1294-1300, 2006
6352006
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
6322018
Overexpression and mutation of p53 in epithelial ovarian cancer
JR Marks, AM Davidoff, BJ Kerns, PA Humphrey, JC Pence, RK Dodge, ...
Cancer research 51 (11), 2979-2984, 1991
5871991
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
5732018
Compromised HOXA5 function can limit p53 expression in human breast tumours
V Raman, SA Martensen, D Reisman, E Evron, WF Odenwald, E Jaffee, ...
Nature 405 (6789), 974, 2000
5492000
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
AT Ferguson, E Evron, CB Umbricht, TK Pandita, TA Chan, H Hermeking, ...
Proceedings of the National Academy of Sciences 97 (11), 6049-6054, 2000
5322000
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
4652018
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
T Baba, PA Convery, N Matsumura, RS Whitaker, E Kondoh, T Perry, ...
Oncogene 28 (2), 209-218, 2009
4402009
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
4022018
BRCA2 mutations in primary breast and ovarian cancers
JM Lancaster, R Wooster, J Mangion, CM Phelan, C Cochran, C Gumbs, ...
Nature genetics 13 (2), 238-240, 1996
3991996
Artificial neural networks improve the accuracy of cancer survival prediction
HB Burke, PH Goodman, DB Rosen, DE Henson, JN Weinstein, ...
Cancer 79 (4), 857-862, 1997
3951997
Genetic basis for p53 overexpression in human breast cancer
AM Davidoff, PA Humphrey, JD Iglehart, JR Marks
Proceedings of the National Academy of Sciences 88 (11), 5006-5010, 1991
3771991
Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.
AM Davidoff, JD Iglehart, JR Marks
Proceedings of the National Academy of Sciences 89 (8), 3439-3442, 1992
3741992
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
3612018
The system can't perform the operation now. Try again later.
Articles 1–20